Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres Ejarque, Deborah Stocken, Shane Solanky et al.|Nature Communications|2021Cited by 49
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres Ejarque, Deborah Stocken, Hira Bahadur Ale et al.|Nature Communications|2021Cited by 1